Antibiotic inhibitors of mitochondrial ATP synthesis

Federation Proceedings
|July 1, 1975
PubMed

Insights

Fourteen antibiotics inhibit mitochondrial ATP synthase by binding to four distinct sites. Venturicidin at site III interferes with leucinostatin binding at site IV, revealing their proximity and interaction.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Mitochondrial ATP synthase is crucial for cellular energy production.
  • Antibiotics targeting ATP synthase can disrupt oxidative phosphorylation.
  • Understanding inhibitor binding sites is key to developing targeted therapies.

Purpose of the Study:

  • To identify and characterize the binding sites of various antibiotics on mitochondrial ATP synthase.
  • To elucidate the mechanism of interaction between different antibiotic binding sites.

Main Methods:

  • Biochemical assays using purified MF1 ATPase and submitochondrial particles.
  • Stoichiometric analysis of inhibitor binding.
  • Assessment of antibiotic effects on ATP synthase activity and oxidative phosphorylation.

Main Results:

  • Four distinct binding sites (I, II, III, IV) for antibiotics were identified on ATP synthase.
  • Aurovertin binds to site I, efrapeptin to site II.
  • Oligomycin, venturicidin, and ossamycin bind to site III; leucinostatin binds to site IV.
  • Venturicidin binding at site III inhibits leucinostatin binding at site IV, suggesting spatial proximity.

Conclusions:

  • Mitochondrial ATP synthase possesses multiple antibiotic binding sites with distinct properties.
  • Sites III and IV are closely located, and venturicidin's interaction with site III influences leucinostatin's binding at site IV.
  • This interaction provides insights into the allosteric regulation of ATP synthase activity by inhibitors.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
The ADP/ATP Carrier Protein01:42

The ADP/ATP Carrier Protein

ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...